Blend Labs, Inc.
1.17USD
+0.0600 (+5.41%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on BLND.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 235.2M | 109.5M | 115.8M | 123.6M | 128.2M | 139.8M |
| Q1 | 71.5M | 37.3M | 23.8M | 26.8M | 30.8M | — |
| Q2 | 65.5M | 42.8M | 28.7M | 31.6M | 33.8M | — |
| Q3 | 55.4M | 40.6M | 33.1M | 32.7M | 32.5M | — |
| Q4 | 42.8M* | -11.2M* | 30.1M* | 31.6M | 31.0M | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | -3.28 | -.760 | -.240 | -.100 | .048 | .060 |
| Q1 | -.320 | -.280 | -.090 | -.060 | -.050 | — |
| Q2 | -2.06 | -.180 | -.090 | -.040 | -.030 | — |
| Q3 | -.570 | -.180 | -.030 | .020 | .007 | — |
| Q4 | -.344* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| -.124* |
| -.003* |
| -.030 |
| .013 |
| — |
Debt level and coverage